documents: FDA-2013-D-1445-0074

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2013-D-1445-0074 FDA FDA-2013-D-1445 Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff Other Guidance 2020-10-05T04:00:00Z 2020 10 2020-10-05T04:00:00Z   2024-11-06T23:40:06Z   1 0 09000064848d3169

Links from other tables